4//SEC Filing
Macomber Lori 4
Accession 0001193125-25-241461
CIK 0001503802other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:25 PM ET
Size
5.0 KB
Accession
0001193125-25-241461
Insider Transaction Report
Form 4
Macomber Lori
EVP, CFO & Treasurer
Transactions
- Award
Common Stock
2025-10-15+43,650→ 54,316 total
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on December 31, 2026.
- [F2]Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001968671
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:25 PM ET
- Size
- 5.0 KB